Correction to: Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products

Affiliations

¹ US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA. Arzu.Selen@fda.hhs.gov.
² Bioneer: FARMA, Department of Pharmacy, University of Copenhagen, 2100, Copenhagen, Denmark.
³ Biopharmaceutics, Pharmaceutical Sciences and Clinical Supply, Merck & Co, Inc., West Point, PA, 19486, USA.
⁴ University of Washington, Seattle, WA, 98195, USA.
⁵ Clinical Pharmacology Department, Global Product Development, Pfizer, Inc., Groton, CT, 06340, USA.
⁶ Seda Pharmaceutical Development Services, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, UK.
⁷ UCB Pharma S.A., Avenue de l'Industrie, 1420, Braine - l'Alleud, Belgium.

Published Erratum

Arzu Selen et al. AAPS J. 2020.

. 2020 Dec 3;23(1):7.

doi: 10.1208/s12248-020-00534-0.

¹ US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA. Arzu.Selen@fda.hhs.gov.
² Bioneer: FARMA, Department of Pharmacy, University of Copenhagen, 2100, Copenhagen, Denmark.
³ Biopharmaceutics, Pharmaceutical Sciences and Clinical Supply, Merck & Co, Inc., West Point, PA, 19486, USA.
⁴ University of Washington, Seattle, WA, 98195, USA.
⁵ Clinical Pharmacology Department, Global Product Development, Pfizer, Inc., Groton, CT, 06340, USA.
⁶ Seda Pharmaceutical Development Services, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, UK.
⁷ UCB Pharma S.A., Avenue de l'Industrie, 1420, Braine - l'Alleud, Belgium.

Abstract

A Correction to this paper has been published: https://doi.org/10.1208/s12248-020-00534-0.

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.
Selen A, Müllertz A, Kesisoglou F, Ho RJY, Cook JA, Dickinson PA, Flanagan T. Selen A, et al. AAPS J. 2020 Jul 27;22(5):97. doi: 10.1208/s12248-020-00470-z. AAPS J. 2020. PMID: 32719954